Megadose Methylprednisolone (MDMP) For Granulocytic Sarcoma (GS)
Journal Title: Turkish Journal of Hematology - Year 2013, Vol 30, Issue 1
Abstract
To the Editor, Baytan et al.’s case report entitled, Cerebellar granulocytic sarcoma: A case report (2012; 19: 177-180), [1] provides an opportunity for me to remind physicians that short-course megadose methylprednisolone (MDMP: 30 mg/kg for 3 d, then 20 mg/kg for 4 d each dose administered over the course of 10-15 min intravenously or orally; calculated dose of powder put into a spoon and then covered with honey and administered before 0600), has been effectively used for the treatment of granulocytic sarcoma (GS) [2,3,4,5]. With this treatment extramedullary relapse rarely occurs, even in patients that develop bone marrow relapse [2].
Authors and Affiliations
Şinasi Özsoylu
Keywords
Related Articles
- EP ID EP100338
- DOI 10.4274/tjh.03779
- Views 65
- Downloads 0
Bullous Sweet’s Syndrome: Report of an Atypical Case Presenting with Ring-Like, Figurate Lesions
Bullous Sweet’s Syndrome: Report of an Atypical Case Presenting with Ring-Like, Figurate Lesions
Participation in Physical and Sportive Activities among Adult Turkish People with Hemophilia: A Single-Center Experience
.
Bringing Packed Red Blood Cells to the Point of Combat Injury: Are We There Yet?
Objective: Hemorrhage is the leading cause of injury-related prehospital mortality. We investigated worst-case scenarios and possible requirements of the Turkish military. As we plan to use blood resources during casualt...
Non-Secretory Multiple Myeloma in a Hemodialysis Patient with Hypercalcemia
To the Editor, Multiple myeloma (MM) develops due to clonal expansion of malign plasma cells. Abnormal plasma cells secrete abnormal immunoglobulins that can be detected monoclonally (M peak) in serum and/or urine via e...
İmatinib Tedavisi Sırasında Kronik Miyeloid Lösemide Gelişen Promiyelositik Blastik Kriz